Literature DB >> 21134394

Cognitive enhancers for anxiety disorders.

Stefan G Hofmann1, Jasper A J Smits, Anu Asnaani, Cassidy A Gutner, Michael W Otto.   

Abstract

Cognitive-behavioral therapy is an effective intervention for anxiety disorders. However, a significant number of people do not respond or only show partial response even after an adequate course of the treatment. Recent research has shown that the efficacy of the intervention can be improved by the use of cognitive enhancers that augment the core learning processes of cognitive-behavior therapy. This manuscript provides a review of the current state of cognitive enhancers for the treatment of anxiety disorders.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21134394      PMCID： PMC3114287          DOI： 10.1016/j.pbb.2010.11.020

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN： 0091-3057            Impact factor:   3.533


  144 in total

1.  The role of ventromedial prefrontal cortex in the recovery of extinguished fear.

Authors:  G J Quirk; G K Russo; J L Barron; K Lebron
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice.

Authors:  Cyril Herry; Rene Garcia
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 3.  Fears born and bred: toward a more inclusive theory of fear acquisition.

Authors:  Richie Poulton; Ross G Menzies
Journal:  Behav Res Ther       Date:  2002-02

4.  Smoking and panic attacks: an epidemiologic investigation.

Authors:  N Breslau; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1999-12

5.  Neurobiological mechanisms by which nicotine mediates different types of anxiety.

Authors:  S E File; S Cheeta; P J Kenny
Journal:  Eur J Pharmacol       Date:  2000-03-30       Impact factor: 4.432

6.  A neural network of obsessive- compulsive disorder: modelling cognitive disinhibition and neurotransmitter dysfunction.

Authors:  D J Stein; J Ludik
Journal:  Med Hypotheses       Date:  2000-08       Impact factor: 1.538

7.  Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms.

Authors:  Yoshio Momose; Miho Murata; Kazuhiro Kobayashi; Masaji Tachikawa; Yuko Nakabayashi; Ichiro Kanazawa; Tatsushi Toda
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

8.  Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects.

Authors:  Y N Wong; S P King; D Simcoe; S Gorman; W Laughton; G C McCormick; P Grebow
Journal:  J Clin Pharmacol       Date:  1999-03       Impact factor: 3.126

Review 9.  The endocannabinoid nervous system: unique opportunities for therapeutic intervention.

Authors:  A C Porter; C C Felder
Journal:  Pharmacol Ther       Date:  2001-04       Impact factor: 12.310

10.  Enhanced memory for emotional material following stress-level cortisol treatment in humans.

Authors:  T W Buchanan; W R Lovallo
Journal:  Psychoneuroendocrinology       Date:  2001-04       Impact factor: 4.905
View more
  20 in total

Review 1.  Pharmacological treatment of anxiety disorders: current treatments and future directions.

Authors:  Frank J Farach; Larry D Pruitt; Janie J Jun; Alissa B Jerud; Lori A Zoellner; Peter P Roy-Byrne
Journal:  J Anxiety Disord       Date:  2012-08-15

2.  The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.

Authors:  Cassidy A Gutner; Joel Weinberger; Stefan G Hofmann
Journal:  Cogn Behav Ther       Date:  2012-09-20

3.  The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

Authors:  Michael L Sulkowski; Daniel A Geller; Adam B Lewin; Tanya K Murphy; Andrew Mittelman; Ashley Brown; Eric A Storch
Journal:  Curr Psychiatry Rev       Date:  2014

4.  Improving Outcome of Psychosocial Treatments by Enhancing Memory and Learning.

Authors:  Allison G Harvey; Jason Lee; Joseph Williams; Steven D Hollon; Matthew P Walker; Monique A Thompson; Rita Smith
Journal:  Perspect Psychol Sci       Date:  2014-03

5.  Inhibiting glycine transporter-1 facilitates cocaine-cue extinction and attenuates reacquisition of cocaine-seeking behavior.

Authors:  Bríd Á Nic Dhonnchadha; Emmanuel Pinard; Daniela Alberati; Joseph G Wettstein; Roger D Spealman; Kathleen M Kantak
Journal:  Drug Alcohol Depend       Date:  2011-10-10       Impact factor: 4.492

6.  Augmentation of exposure therapy with post-session administration of D-cycloserine.

Authors:  Candyce D Tart; Pamela R Handelsman; Lindsey B Deboer; David Rosenfield; Mark H Pollack; Stefan G Hofmann; Mark B Powers; Michael W Otto; Jasper A J Smits
Journal:  J Psychiatr Res       Date:  2012-10-23       Impact factor: 4.791

7.  D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.

Authors:  Stefan G Hofmann; Jasper A J Smits; David Rosenfield; Naomi Simon; Michael W Otto; Alicia E Meuret; Luana Marques; Angela Fang; Candyce Tart; Mark H Pollack
Journal:  Am J Psychiatry       Date:  2013-07       Impact factor: 18.112

8.  D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

Authors:  Jasper A J Smits; David Rosenfield; Michael W Otto; Mark B Powers; Stefan G Hofmann; Michael J Telch; Mark H Pollack; Candyce D Tart
Journal:  Biol Psychiatry       Date:  2013-01-16       Impact factor: 13.382

9.  D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.

Authors:  Jasper A J Smits; David Rosenfield; Michael W Otto; Luana Marques; Michelle L Davis; Alicia E Meuret; Naomi M Simon; Mark H Pollack; Stefan G Hofmann
Journal:  J Psychiatr Res       Date:  2013-07-16       Impact factor: 4.791

10.  D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.

Authors:  Jasper A J Smits; Stefan G Hofmann; David Rosenfield; Lindsey B DeBoer; Paul T Costa; Naomi M Simon; Conall O'Cleirigh; Alicia E Meuret; Luana Marques; Michael W Otto; Mark H Pollack
Journal:  J Consult Clin Psychol       Date:  2013-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.